115 related articles for article (PubMed ID: 165016)
1. Relationship between serum cholinesterase and low density lipoproteins in children with nephrotic syndrome.
Way RC; Hutton CJ; Kutty KM
Clin Biochem; 1975 Apr; 8(2):103-7. PubMed ID: 165016
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.
Chu MI; Fontaine P; Kutty KM; Murphy D; Redheendran R
Clin Chim Acta; 1978 Apr; 85(1):55-9. PubMed ID: 206388
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
Titov VN; Tvorogova MG; Levitova EN; Krylova EA
Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
[TBL] [Abstract][Full Text] [Related]
5. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
Faucher C; Albert C; Beaufils H; Jouanneau C; Dupouet L
Nephrol Dial Transplant; 1997 May; 12(5):1037-9. PubMed ID: 9175066
[No Abstract] [Full Text] [Related]
6. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome.
Zilleruelo G; Hsia SL; Freundlich M; Gorman HM; Strauss J
J Pediatr; 1984 Jan; 104(1):61-4. PubMed ID: 6690676
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein levels in children with nephrotic syndrome.
Benakappa DG; Rao AS; Sastry NS
Indian Pediatr; 1976 Apr; 13(4):287-9. PubMed ID: 181320
[No Abstract] [Full Text] [Related]
8. Lipoprotein distribution and composition in the human nephrotic syndrome.
Muls E; Rosseneu M; Daneels R; Schurgers M; Boelaert J
Atherosclerosis; 1985 Feb; 54(2):225-37. PubMed ID: 3986019
[TBL] [Abstract][Full Text] [Related]
9. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
[TBL] [Abstract][Full Text] [Related]
11. Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome.
Chan MK; Persaud JW; Varghese Z; Moorhead JF
Aust N Z J Med; 1984 Dec; 14(6):841-7. PubMed ID: 6598053
[TBL] [Abstract][Full Text] [Related]
12. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
Michaeli J; Bar-On H; Shafrir E
Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
[TBL] [Abstract][Full Text] [Related]
14. Serum cholinesterase isoenzymes and the WHHL rabbit: the relationship between the activity of cholinesterase not bound to low-density-lipoprotein and lipoprotein titer.
Udom C; Barnard D; Smith T
Mol Cell Biochem; 1989 Oct; 90(2):121-5. PubMed ID: 2586493
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
Dirican M; Taş S; Sarandöl E; Tokullugil HA
Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
[TBL] [Abstract][Full Text] [Related]
16. Serum beta -- lipoproteins: studies in a patient and in guinea pigs after the ingestion of organophosphorus compounds.
Kutty KM; Jocob JC; Hutton CJ; Davis PJ; Peterson SC
Clin Biochem; 1975 Dec; 8(6):379-83. PubMed ID: 173478
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells.
Krämer A; Nauck M; Pavenstädt H; Schwedler S; Wieland H; Schollmeyer P; Wanner C
Kidney Int; 1993 Dec; 44(6):1341-51. PubMed ID: 8301935
[TBL] [Abstract][Full Text] [Related]
18. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Vaziri ND
Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.
Skrzep-Poloczek B; Tomasik A; Tarnawski R; Hyla-Klekot L; Dyduch A; Wojciechowska C; Wesolowski W; Kopieczna-Grzebieniak E; Zalejska-Fiolka J; Widera E
Nephron; 2001 Sep; 89(1):68-72. PubMed ID: 11528235
[TBL] [Abstract][Full Text] [Related]
20. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
Braschi S; Masson D; Rostoker G; Florentin E; Athias A; Martin C; Jacotot B; Gambert P; Lallemant C; Lagrost L
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2559-67. PubMed ID: 9409228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
